Latest Blog Posts Tagged "Motor Fluctuations"
February 09, 2017
Pharmaceutical company Acorda reported positive results from a Phase III trial of an inhaled form of levodopa to treat "off" periods in Parkinson's.
September 01, 2016
In the last few months, Cynapsus Therapeutics Inc. has announced Phase II results of its under-the-tongue strip to alleviate motor symptoms, FDA Fast Track Designation and a buyout.
May 23, 2016
In this video, Dr. Dolhun discusses how and why "off" times — or motor fluctuations — may occur, as well as current management options and therapies in development.
January 07, 2016
MJFF, Cynapsus and Intel announce a pilot incorporating wearable devices and "big data" approaches into a trial of a drug to help patients return to "on" from "off" episodes.
September 21, 2015
Dystonia, a neurological disorder that causes involuntary muscle contractions, can exist on its own or as part of Parkinson's disease.
December 30, 2014
A belt-worn pump that delivers levodopa/carbidopa continuously under the skin may help alleviate the motor fluctuations associated with traditional, oral therapy.
November 10, 2014
This summer we asked people with Parkinson's to take a survey on the impact of "off" episodes. The results are part of discussions MJFF is leading with groups that make medication coverage decisions.
October 30, 2014
The FDA has approved Israeli company Intec Pharma Ltd. to carry out a Phase III trial of the Accordion Pill for treatment of Parkinson's. The study is expected to begin in the second half of 2015.
June 16, 2014
CEO Todd Sherer, PhD, talks to Dave Iverson about why levodopa loses efficacy over time and new therapies in development to even out on/off cycles.
November 21, 2013
Unpredictable on/off periods can greatly interfere with daily life, and are perhaps the major concern for today's patients. That's why MJFF is hard at work to improve existing treatments.